Annual Revenue
$46.66 B
+$3.20 B+7.36%
31 December 2023
Summary
Novartis AG annual revenue is currently $46.66 billion, with the most recent change of +$3.20 billion (+7.36%) on 31 December 2023. During the last 3 years, it has fallen by -$3.24 billion (-6.49%). NVS annual revenue is now -21.41% below its all-time high of $59.38 billion, reached on 31 December 2011.NVS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$13.17 B
+$300.00 M+2.33%
30 September 2024
Summary
Novartis AG quarterly revenue is currently $13.17 billion, with the most recent change of +$300.00 million (+2.33%) on 30 September 2024. Over the past year, it has increased by +$1.08 billion (+8.93%). NVS quarterly revenue is now -12.90% below its all-time high of $15.12 billion, reached on 30 June 2011.NVS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$49.94 B
+$1.08 B+2.21%
30 September 2024
Summary
Novartis AG TTM revenue is currently $49.94 billion, with the most recent change of +$1.08 billion (+2.21%) on 30 September 2024. Over the past year, it has increased by +$4.09 billion (+8.92%). NVS TTM revenue is now -15.89% below its all-time high of $59.38 billion, reached on 31 December 2011.NVS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.4% | +8.9% | +8.9% |
| 3 y3 years | -6.5% | -1.5% | -4.7% |
| 5 y5 years | +1.2% | +5.5% | +4.3% |
NVS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.5% | +7.4% | -1.5% | +185.2% | -4.7% | +20.9% |
| 5 y | 5 years | -6.5% | +7.4% | -1.5% | +185.2% | -4.7% | +20.9% |
| alltime | all time | -21.4% | +148.7% | -12.9% | +207.9% | -15.9% | +776.6% |
Novartis AG Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.17 B(+2.3%) | $49.94 B(+2.2%) |
| June 2024 | - | $12.87 B(+6.2%) | $48.86 B(+2.4%) |
| Mar 2024 | - | $12.12 B(+2.9%) | $47.73 B(+2.3%) |
| Dec 2023 | $46.66 B(+7.4%) | $11.78 B(-2.6%) | $46.66 B(+1.8%) |
| Sept 2023 | - | $12.09 B(+3.0%) | $45.85 B(+2.9%) |
| June 2023 | - | $11.74 B(+6.3%) | $44.54 B(-2.9%) |
| Mar 2023 | - | $11.05 B(+0.7%) | $45.88 B(-3.7%) |
| Dec 2022 | $43.46 B(-1.2%) | $10.97 B(+1.7%) | $47.65 B(+15.4%) |
| Sept 2022 | - | $10.78 B(-17.6%) | $41.30 B(-5.9%) |
| June 2022 | - | $13.09 B(+2.1%) | $43.88 B(-0.5%) |
| Mar 2022 | - | $12.81 B(+177.4%) | $44.09 B(+0.3%) |
| Dec 2021 | $43.97 B(-11.9%) | $4.62 B(-65.4%) | $43.97 B(-16.1%) |
| Sept 2021 | - | $13.37 B(+0.5%) | $52.38 B(+1.6%) |
| June 2021 | - | $13.29 B(+4.7%) | $51.56 B(+3.4%) |
| Mar 2021 | - | $12.69 B(-2.6%) | $49.88 B(-0.0%) |
| Dec 2020 | $49.90 B(+2.5%) | $13.03 B(+3.9%) | $49.90 B(+0.6%) |
| Sept 2020 | - | $12.54 B(+7.9%) | $49.58 B(+0.1%) |
| June 2020 | - | $11.62 B(-8.5%) | $49.53 B(-0.8%) |
| Mar 2020 | - | $12.71 B(-0.1%) | $49.93 B(+2.6%) |
| Dec 2019 | $48.68 B(+5.6%) | $12.72 B(+1.9%) | $48.68 B(+1.7%) |
| Sept 2019 | - | $12.48 B(+3.8%) | $47.86 B(+2.3%) |
| June 2019 | - | $12.02 B(+5.0%) | $46.76 B(+0.8%) |
| Mar 2019 | - | $11.46 B(-3.7%) | $46.39 B(+0.6%) |
| Dec 2018 | $46.10 B(+6.2%) | $11.90 B(+4.5%) | $46.10 B(+13.4%) |
| Sept 2018 | - | $11.39 B(-2.3%) | $40.63 B(-3.1%) |
| June 2018 | - | $11.65 B(+4.4%) | $41.94 B(-2.0%) |
| Mar 2018 | - | $11.16 B(+73.5%) | $42.78 B(-1.4%) |
| Dec 2017 | $43.40 B(-12.2%) | $6.43 B(-49.3%) | $43.40 B(-12.5%) |
| Sept 2017 | - | $12.69 B(+1.6%) | $49.58 B(+0.7%) |
| June 2017 | - | $12.49 B(+6.0%) | $49.23 B(-0.4%) |
| Mar 2017 | - | $11.79 B(-6.5%) | $49.41 B(-0.1%) |
| Dec 2016 | $49.44 B(-1.9%) | $12.61 B(+2.1%) | $49.44 B(-0.4%) |
| Sept 2016 | - | $12.34 B(-2.7%) | $49.63 B(-0.3%) |
| June 2016 | - | $12.68 B(+7.4%) | $49.78 B(-0.4%) |
| Mar 2016 | - | $11.81 B(-7.8%) | $49.99 B(-0.8%) |
| Dec 2015 | $50.39 B(-6.1%) | $12.80 B(+2.6%) | $50.39 B(-1.1%) |
| Sept 2015 | - | $12.48 B(-3.2%) | $50.94 B(-1.6%) |
| June 2015 | - | $12.90 B(+5.7%) | $51.75 B(-2.0%) |
| Mar 2015 | - | $12.20 B(-8.6%) | $52.80 B(-1.5%) |
| Dec 2014 | $53.63 B(+1.7%) | $13.35 B(+0.4%) | $53.63 B(-0.5%) |
| Sept 2014 | - | $13.30 B(-4.7%) | $53.91 B(+0.7%) |
| June 2014 | - | $13.95 B(+7.0%) | $53.51 B(+1.3%) |
| Mar 2014 | - | $13.03 B(-4.4%) | $52.84 B(-2.2%) |
| Dec 2013 | $52.72 B(+1.4%) | $13.63 B(+5.6%) | $54.02 B(+8.3%) |
| Sept 2013 | - | $12.91 B(-2.8%) | $49.87 B(-2.2%) |
| June 2013 | - | $13.28 B(-6.5%) | $51.00 B(-2.4%) |
| Mar 2013 | - | $14.21 B(+49.9%) | $52.26 B(+0.6%) |
| Dec 2012 | $51.97 B | $9.48 B(-32.5%) | $51.97 B(-9.6%) |
| Sept 2012 | - | $14.04 B(-3.5%) | $57.49 B(-1.7%) |
| June 2012 | - | $14.54 B(+4.5%) | $58.48 B(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $13.91 B(-7.2%) | $59.07 B(-0.5%) |
| Dec 2011 | $59.38 B(+15.2%) | $15.00 B(-0.3%) | $59.38 B(+0.9%) |
| Sept 2011 | - | $15.03 B(-0.6%) | $58.84 B(+3.9%) |
| June 2011 | - | $15.12 B(+6.3%) | $56.63 B(+6.0%) |
| Mar 2011 | - | $14.22 B(-1.7%) | $53.43 B(+3.6%) |
| Dec 2010 | $51.56 B(+14.3%) | $14.46 B(+12.8%) | $51.56 B(+2.6%) |
| Sept 2010 | - | $12.82 B(+7.5%) | $50.24 B(+3.1%) |
| June 2010 | - | $11.92 B(-3.5%) | $48.71 B(+2.5%) |
| Mar 2010 | - | $12.36 B(-6.0%) | $47.53 B(+5.4%) |
| Dec 2009 | $45.10 B(+5.9%) | $13.14 B(+16.4%) | $45.10 B(+6.6%) |
| Sept 2009 | - | $11.29 B(+5.1%) | $42.31 B(+0.6%) |
| June 2009 | - | $10.74 B(+8.2%) | $42.05 B(-0.6%) |
| Mar 2009 | - | $9.93 B(-4.1%) | $42.29 B(-0.7%) |
| Dec 2008 | $42.58 B(+9.3%) | $10.35 B(-6.2%) | $42.58 B(+0.4%) |
| Sept 2008 | - | $11.03 B(+0.4%) | $42.41 B(+2.9%) |
| June 2008 | - | $10.99 B(+7.6%) | $41.20 B(+4.0%) |
| Mar 2008 | - | $10.22 B(+0.4%) | $39.60 B(+2.2%) |
| Dec 2007 | $38.95 B(+10.9%) | $10.17 B(+3.6%) | $38.76 B(+1.4%) |
| Sept 2007 | - | $9.82 B(+4.4%) | $38.25 B(+2.1%) |
| June 2007 | - | $9.40 B(+0.3%) | $37.45 B(+2.4%) |
| Mar 2007 | - | $9.37 B(-2.9%) | $36.56 B(+3.5%) |
| Dec 2006 | $35.10 B(+18.0%) | $9.65 B(+7.0%) | $35.34 B(+11.6%) |
| Sept 2006 | - | $9.02 B(+6.1%) | $31.66 B(+1.7%) |
| June 2006 | - | $8.51 B(+4.4%) | $31.13 B(+2.1%) |
| Mar 2006 | - | $8.15 B(+36.3%) | $30.49 B(+2.7%) |
| Dec 2005 | $29.75 B(+9.1%) | $5.98 B(-29.6%) | $29.68 B(-2.1%) |
| Sept 2005 | - | $8.49 B(+7.9%) | $30.31 B(+5.0%) |
| June 2005 | - | $7.87 B(+7.2%) | $28.88 B(+3.2%) |
| Mar 2005 | - | $7.34 B(+11.1%) | $27.98 B(+2.6%) |
| Dec 2004 | $27.28 B(+9.4%) | $6.61 B(-6.4%) | $27.28 B(-0.7%) |
| Sept 2004 | - | $7.06 B(+1.2%) | $27.46 B(+3.2%) |
| June 2004 | - | $6.97 B(+5.0%) | $26.62 B(+3.0%) |
| Mar 2004 | - | $6.64 B(-2.3%) | $25.85 B(+3.7%) |
| Dec 2003 | $24.93 B(+19.4%) | $6.80 B(+9.4%) | $24.93 B(+5.3%) |
| Sept 2003 | - | $6.21 B(+0.1%) | $23.66 B(+5.1%) |
| June 2003 | - | $6.20 B(+8.4%) | $22.51 B(+2.8%) |
| Mar 2003 | - | $5.72 B(+3.4%) | $21.91 B(+4.1%) |
| Dec 2002 | $20.88 B(+11.3%) | $5.53 B(+9.3%) | $21.05 B(+4.8%) |
| Sept 2002 | - | $5.06 B(-9.6%) | $20.08 B(-2.5%) |
| June 2002 | - | $5.60 B(+15.2%) | $20.60 B(+6.7%) |
| Mar 2002 | - | $4.86 B(+6.4%) | $19.31 B(+2.2%) |
| Dec 2001 | $18.76 B(-15.4%) | $4.57 B(-18.1%) | $18.89 B(-8.5%) |
| Sept 2001 | - | $5.58 B(+29.3%) | $20.64 B(+3.5%) |
| June 2001 | - | $4.31 B(-2.9%) | $19.95 B(+0.2%) |
| Mar 2001 | - | $4.44 B(-29.7%) | $19.91 B(-5.9%) |
| Dec 2000 | $22.18 B(+8.8%) | $6.31 B(+29.4%) | $21.17 B(+42.5%) |
| Sept 2000 | - | $4.88 B(+14.1%) | $14.86 B(+48.9%) |
| June 2000 | - | $4.28 B(-24.9%) | $9.97 B(+75.1%) |
| Mar 2000 | - | $5.70 B | $5.70 B |
| Dec 1999 | $20.39 B(-11.5%) | - | - |
| Dec 1998 | $23.04 B | - | - |
FAQ
- What is Novartis AG annual revenue?
- What is the all time high annual revenue for Novartis AG?
- What is Novartis AG annual revenue year-on-year change?
- What is Novartis AG quarterly revenue?
- What is the all time high quarterly revenue for Novartis AG?
- What is Novartis AG quarterly revenue year-on-year change?
- What is Novartis AG TTM revenue?
- What is the all time high TTM revenue for Novartis AG?
- What is Novartis AG TTM revenue year-on-year change?
What is Novartis AG annual revenue?
The current annual revenue of NVS is $46.66 B
What is the all time high annual revenue for Novartis AG?
Novartis AG all-time high annual revenue is $59.38 B
What is Novartis AG annual revenue year-on-year change?
Over the past year, NVS annual revenue has changed by +$3.20 B (+7.36%)
What is Novartis AG quarterly revenue?
The current quarterly revenue of NVS is $13.17 B
What is the all time high quarterly revenue for Novartis AG?
Novartis AG all-time high quarterly revenue is $15.12 B
What is Novartis AG quarterly revenue year-on-year change?
Over the past year, NVS quarterly revenue has changed by +$1.08 B (+8.93%)
What is Novartis AG TTM revenue?
The current TTM revenue of NVS is $49.94 B
What is the all time high TTM revenue for Novartis AG?
Novartis AG all-time high TTM revenue is $59.38 B
What is Novartis AG TTM revenue year-on-year change?
Over the past year, NVS TTM revenue has changed by +$4.09 B (+8.92%)